|

Intravenous infusion anti-CEA-CAR-T cell Clinical Trials

1 actively recruiting trial

Also known as: cyclophosphamide, fludarabine

Pipeline

Phase 1: 1

Top Sponsors

  • China Medical University, China1

Indications

  • Carcinoma1
  • Cancer1

Other1 trial

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.